Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Sep. 26, 2014	Sep. 27, 2013
Current assets:
Cash and cash equivalents	$ 568,472	$ 454,397
Restricted cash	2,142	3,175
Short-term investments	231,208	140,267
Accounts receivable, net of allowance for doubtful accounts of $1,615 and $514	86,168	97,460
Inventories	8,536	10,093
Deferred taxes	86,445	84,238
Prepaid expenses and other current assets	22,880	28,949
Total current assets	1,005,851	818,579
Long-term investments	296,335	306,338
Property, plant and equipment, net	289,755	242,917
Intangible assets, net	63,700	41,315
Goodwill	277,574	279,724
Deferred taxes	41,746	37,434
Other non-current assets	9,051	11,638
Total assets	1,984,012	1,737,945
Current liabilities:
Accounts payable	15,898	10,695
Accrued liabilities	158,376	137,795
Income taxes payable	2,600	3,394
Deferred revenue	12,496	20,931
Total current liabilities	189,370	172,815
Long-term deferred revenue	19,279	19,663
Other non-current liabilities	43,715	45,441
Total liabilities	252,364	237,919
Stockholders' equity:
Additional paid-in capital	46,415	18,812
Retained earnings	1,660,485	1,454,382
Accumulated other comprehensive income	3,014	7,814
Total stockholders’ equity – Dolby Laboratories, Inc.	1,710,017	1,481,110
Controlling interest	21,631	18,916
Total stockholders’ equity	1,731,648	1,500,026
Total liabilities and stockholders’ equity	1,984,012	1,737,945
Class A Common Stock [Member]
Stockholders' equity:
Common stock	51	47
Class B Common Stock [Member]
Stockholders' equity:
Common stock	$ 52	$ 55